Mode
Text Size
Log in / Sign up

Clinical Trial Search

Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.

Phase
Intervention
Population
Results posted

30 closest matches · ranked by relevance

Phase 3 N=388 Dysport® Adult Lower Limb Spasticity Study

Leg Spasticity
Primary: Least Squares Mean Change From Baseline to Week 4 in the MAS Score in the Gastrocnemius-soleus Complex (GSC) (Knee Extended) — -0.6; -0.8; -0.5 units on a scale…
Ipsen Results Oct 2017 4.4% serious AE View details

Phase 3 N=345 Dysport® Adult Lower Limb Spasticity Follow-on Study

Post-stroke Spasticity · Spasticity Post-Traumatic Brain Injury
Primary: Assessment of the Long-Term Safety of Dysport® Through the Collection of Treatment Emergent Adverse Events (TEAEs) — 140; 97; 47; 21 participants
Ipsen Results Nov 2017 12.5% serious AE View details

Phase 4 N=274 BOTOX® Economic Spasticity Trial (BEST)

Muscle Spasticity
Primary: Physician Assessment of Success, as Determined by Percentage of Patients Who Achieve Their Principal Active Functional Goal at Week 24 — 40.9; 33.3 Percentage of Patients
Allergan Results Aug 2012 33.7% serious AE View details

Phase 3 N=235 BOTOX® Treatment in Pediatric Upper Limb Spasticity

Pediatrics · Muscle Spasticity · Cerebral Palsy
Primary: Average Change From Baseline in Modified Ashworth Scale-Bohannon (MAS-B) Score of the Principal Muscle Group at Weeks 4 and 6 — -1.87; -1.92; -1.21 score on a scale…
Allergan Results Aug 2018 2.1% serious AE View details